Michael Vogelbaum, MD, PhD
4 clinical trials · Sponsor
◉ Watch Michael Vogelbaum, MD, PhD
| Record | Firm | Date |
|---|---|---|
| Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy (NCT03193463) | Michael Vogelbaum, MD, PhD | 2017-11-03 |
Track Michael Vogelbaum, MD, PhD automatically
Every clearance here is in the API, with alerts when new ones post.